Multi-CAR-T Cells Targeting B Cell Lymphomas

Clinical trial NCT04429438 · RECRUITING

Trial details

NCT number: NCT04429438
Sponsor: Shenzhen Geno-Immune Medical Institute
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B Cell Lymphoma (BCL)

Start date: 2026-06-01
Primary completion: 2029-12-31
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.